Liboran (Acetylcysteine)

Acetylcysteine breaks disulfide bonds in mucus glycoproteins, reducing the viscosity of the secretions. This chemical action makes the mucus less sticky, allowing ciliary movement and coughing to clear it more effectively. The compound also replenishes intracellular glutathione, supporting antioxidant defenses in the airway epithelium.

The appropriate dose of Liboran is determined by a qualified prescriber based on the patient’s age, condition, and clinical response. Because dosing can vary, it is essential to follow the specific instructions provided by the healthcare professional who prescribed the medication.

Safety data for Liboran in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before starting treatment with acetylcysteine.

To order Liboran, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide, and will request verification of trade or institutional credentials. The sales team will then respond with pricing, availability, shipping details (including any temperature requirements), and necessary import documentation.

Liboran’s active ingredient, acetylcysteine, is a thiol‑containing mucolytic that directly cleaves disulfide bonds in mucus, whereas other agents such as carbocisteine or bromhexine act mainly by stimulating serous gland secretion. Acetylcysteine also provides antioxidant benefits by boosting glutathione, which can be advantageous in oxidative stress‑related lung conditions.

Liboran should be stored at room temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture, and store it away from direct sunlight or heat sources to maintain its stability and potency.

Liboran is taken orally as directed by a healthcare professional. The tablet or liquid is swallowed with water, and the dose may be repeated according to the prescriber’s instructions. It is typically taken with or without food, depending on the specific guidance provided.

Serious adverse reactions, although rare, include anaphylaxis, severe skin reactions such as Stevens‑Johnson syndrome, bronchospasm, hepatic dysfunction, and neutropenia. Patients should seek immediate medical attention if they experience signs of an allergic reaction, difficulty breathing, or unusual skin changes.

Liboran should be avoided in individuals with known hypersensitivity to acetylcysteine or any of the product’s excipients. Patients with uncontrolled asthma may be at higher risk for bronchospasm and should use the medication only under close medical supervision.